Pilot open-label study of triazolam in the treatment of insomnia following alcohol withdrawal.
Insomnia and anxiety decreased in 12 outpatients taking triazolam following alcohol withdrawal.
D000328:Adult; D000437:Alcoholism / Q000534:rehabilitation*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D014229:Triazolam / Q000008:administration & dosage / Q000627:therapeutic use*
D014151:Anti-Anxiety Agents; D014229:Triazolam